Active, Not Recruiting
Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation
NCT07094464
- Conditions
- Allogeneic Hematopoietic Stem Cell Transplantation, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
- Locations
-
- Chinese PLA General Hospital Beijing, Beijing Municipality, China